HPV Vaccine Provides Long-Lasting Protection for Women Living with HIV

Research published in *The Lancet HIV* demonstrates that the Human Papillomavirus (HPV) vaccine offers strong and sustained protection for women living with HIV. This study, which followed participants for up to nine years, provides the longest-term evidence to date on the vaccine's effectiveness in this vulnerable population, who are at a significantly higher risk of HPV infection and cervical cancer.